Saturday 17 October 2026
Export COO’s income statement to Excel — free account
The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
57.94
0.54
+0.94%
Follow COO
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| 6.84% | 2.85% | 4.87% | 4.59% | ||
| 4.55% | 1.89% | 3.26% | 3.03% | ||
ROIC |
3.17% | 2.95% | 4.15% | 4.01% | |
Return on Tangible Assets |
22.28% | 8.97% | 15.12% | 12.19% | |
Average Days of Receivables |
67.96 | 69.81 | 70.96 | 73.94 | |
Free Cash Flow per Share |
3.51 | 2.92 | 2.51 | 2.18 | |
Free Cash Flow |
678.00 | 569.50 | 491.20 | 433.70 | |
Capital Expenditures |
(355.30) | (383.50) | (375.20) | (362.40) | |
| Other line items | |||||
Cash ROIC |
6.15% | 5.25% | 4.47% | 4.00% | |
Accounts Receivable Turnover |
5.36 | 5.32 | 5.45 | 5.29 | |
Accounts Payable Turnover |
5.69 | 6.11 | 6.72 | 5.03 | |
Inventory Turnover |
1.61 | 1.64 | 1.67 | 1.71 | |
Average Days of Payables |
63.51 | 58.42 | 57.45 | 77.75 | |
Days of Inventory on Hand |
230.46 | 224.47 | 222.96 | 218.95 | |
Tax Rate |
0.23 | (0.43) | (0.34) | (0.34) | |
Research and Development Expense of Revenue |
4.01% | 4.08% | 4.23% | 4.21% | |
Selling, General and Administrative Expense of Revenue |
44.53% | 45.08% | 39.26% | 39.78% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 6.40% | |
Interest Coverage |
6.10 | 5.35 | 7.40 | 6.83 | |
Operating CF/Net income |
1.81 | 4.04 | 2.16 | 2.12 | |
Depreciation/Fixed assets |
0.18 | 0.18 | 0.18 | 0.18 | |
Capex/Depreciation |
(0.93) | (1.00) | (0.98) | (0.96) | |
Revenue per Share |
21.95 | 21.70 | 21.20 | 20.55 | |
Operating CF per Share |
5.35 | 4.89 | 4.42 | 4.00 | |
Capex per Share |
(1.84) | (1.97) | (1.92) | (1.82) | |
Capex to Sales |
0.08 | 0.09 | 0.09 | 0.09 |
Columns are period end dates